Results 91 to 100 of about 159,740 (164)

Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - California, October 2025-January 2026. [PDF]

MMWR Morb Mortal Wkly Rep
Zhu S, Quint J, León TM, Li NJ, Muldrew S, Porse C, Flannery B, Ellington S, Murray EL, Sachdev D, McCullough K, Schechter R.   +11 more
europepmc   +1 more source

Influenza Activity and Estimated Vaccine Effectiveness During the 2025-2026 Influenza Season.

JAMA Netw Open
Azziz-Baumgartner E, Budd A, Lee JS, Iuliano AD, Ellington SR, Levine MZ, Zheng XY, Gubareva L, Adams K, DeCuir J, Bozio CH, Reed C, Kirby MK, Rambo-Martin B, Jones JM, Biggerstaff M, Garg S, Davis CT, Shimabukuro TT, Burns E, Kondor R, Olsen SJ, Dugan VG, VISION Coauthors, Irving SA, Naleway AL, Dascomb K, Sheffield T, DeSilva MB, Tartof SY, Sy LS, Klein NP, Zerbo O, Grannis SJ, Dixon BE, Stockwell MS, Stephens AB, Ong TC, Barron MA, Ball SW, Weber ZA, Reeves EL, Ray CS.   +42 more
europepmc   +1 more source

COVID-19 vaccine effectiveness in patients with lung cancer: challenges in the Omicron era. [PDF]

BMC Infect Dis
Hosseini-Moghaddam SM, Swayze S, Kwong JC, Shepherd FA.   +3 more
europepmc   +1 more source

Respiratory syncytial virus (RSV) vaccine effectiveness and antibody correlates of protection among older adults in the Community Vaccine Effectiveness (CoVE) observational study. [PDF]

EBioMedicine
Godonou ET, Callear AP, Juntila-Raymond CL, Raji D, Smith M, Rumfelt KE, Midgley CM, Feldstein LR, Jones JM, Hagen MB, Eisenberg MC, Lauring AS, Monto AS, Wagner AL, Martin ET.   +14 more
europepmc   +1 more source

COVID-19 Vaccine Effectiveness in Patients With Hematologic Malignancies: A Nationwide Cohort Study. [PDF]

J Infect Dis
Hofsink Q, Lissenberg-Witte BI, Haggenburg S, Goorhuis A, Hazenberg MD, Rutten CE, den Tex P, de Vries EGE, van der Veldt AAM, Kemmeren JM, de Keizer NF, Huijgens PC, Dinmohamed AG, van Roon A, Pijpers J, van Roekel C, van den Hof S, Hahné SJM, de Gier B, Heijmans J, Nijhof IS.   +20 more
europepmc   +1 more source

Target Trial Emulation of Vaccine Effectiveness in 5- to 17-years-olds with Prior SARS-CoV-2 Infection. [PDF]

Nat Commun
Lei Y, Chen J, Wu Q, Zhou T, Zhang B, Becich MJ, Bisyuk Y, Blecker S, Chrischilles EA, Christakis DA, Cowell LG, Cummins MR, Fernandez SA, Fort D, Gonzalez SL, Herring SJ, Horne BD, Horowitz C, Liu M, Kim S, Mirhaji P, Mosa ASM, Muszynski JA, Paules CI, Sato AI, Schwenk HT, Sengupta S, Suresh S, Taylor BW, Williams DA, He Y, Morris JS, Jhaveri R, Forrest CB, Chen Y, RECOVER Consortium.   +35 more
europepmc   +1 more source

Mumps Virus: Replication, Immune Response, and the Changing Landscape of Vaccine Effectiveness. [PDF]

Pathogens
Risalvato J.
europepmc   +1 more source

Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study. [PDF]

Am J Epidemiol
Kissling E, Nunes B, Hooiveld M, Martínez-Baz I, Monge S, Robertson C, Knol M, Sève N, Mlinarić I, Domegan L, Machado A, Whitaker H, Lazar M, Meijer A, Enkirch T, Casado I, Pérez-Gimeno G, William N, Enouf V, Kurečić Filipović S, McKenna A, Rodrigues AP, de Lusignan S, Timnea OC, Latorre-Margalef N, Castilla J, Pozo F, Hamilton M, Masse S, Ilić M, Basile L, O'Donnell J, Guiomar R, Riess M, Popescu RM, Rose AMC, Andrews N, Bacci S, Pastore Celentano L, Valenciano M, Moren A, Beutels P, Hens N, I-MOVE-COVID-19 and ECDC primary care study teams.   +43 more
europepmc   +1 more source

Over- and under-estimation of vaccine effectiveness. [PDF]

BMC Med Res Methodol
De-Leon H, Aran D.
europepmc   +1 more source

Estimates of vaccine effectiveness against measles and mumps: 14 years follow-up of a large cohort in Wales, UK. [PDF]

Int J Epidemiol
Perry M, Gravenor MB, Cottrell S, Moore C, Griffiths LJ.   +4 more
europepmc   +1 more source